| ORIGINAL ARTICLE |
|
| Year : 2019 | Volume
: 16
| Issue : 2 | Page : 99-103 |
|
|
Compliance to antituberculous drugs among patients in Erbil, Kurdistan Region of Iraq
Shapol Jalal Kokha Ubed1, Hamanejm H Jaff2
1 Department of Medicine, Respiratory Unit, Rizgari Hospital, Erbil, Iraq
2 Kurdistan Board for Medical Specialities, Ministry of Higher Education and Research, Erbil, Iraq
Correspondence Address:
Shapol Jalal Kokha Ubed
Department of Medical, Respiratory Unit, Rizgari Hospital, Erbil
Iraq
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/MJBL.MJBL_1_19
|
|
|
Introduction: In Erbil, Kurdistan region of Iraq, some patients registered with tuberculosis (TB) diagnosis in Chest and Respiratory Diseases Center have interrupted treatment before completing their course, and many patients take their treatment irregularly due to different reasons. In this study, we try to determine the percentage of patients who are noncompliant to antituberculous drugs, to know the causes of noncompliance and to compare the outcome of patients taking drugs irregularly to those who take them regularly. Materials and Methods: Patients enrolled in this study were those who were diagnosed as having TB and registered in Erbil Chest and Respiratory Center during the years 2015 and 2016. Data were collected from patient forms and registers. For most patients, the causes of interruption in the course of treatment are not documented in the registers, and thus patients had been called by phone to know factors behind that. Results: Among 394 patients registered in this study, it was found that 57 patients (15%) registered to having TB have been registered as default from the treatment and 14 patients (3.55%) have interrupted their treatment because they had been wrongly diagnosed as TB. Fifteen patients (3.8%) have completed their treatment, but their follow-up was not documented. One (0.25%) of the patients completed his treatment outside Iraq. Another patient was originally from other governorates (Al-Anbar) and completed his treatment when he returned to his governorate. Two (0.5%) were non-Iraqi patients who returned to their countries and their outcome is unknown. Five (1.27%) of the patients stopped treatment due to side effects of drugs; three (0.8) of them were told by the referring doctor to stop treatment. Conclusion: Most TB-infected patients who were registered in Erbil Chest and Respiratory Diseases Center were compliant to the treatment but with occasional interruptions. Not all patients who were registered as default were really defaulters as many of those have completed their treatment, but their follow-up was not documented, and many were misdiagnosed as TB.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
